Evaluation of Growth Hormone Secretion and Treatment

References

• Hlndmarsh P, Smith P H, Brook C GD, et al. The relationship between height velocity, and growth hormone secretion in short prepubertal children. Clin Endocrinol 1967; 27: 581–91
   Google Scholar
• Alien D B, Post N C. Growlh hormone therapy for short stature: panacea or Pandora's box?. J Pediatr 1990; 117: 16–21
   PubMed Web of Science ®Google Scholar
• Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg W B. Growlh hormone‐releasing factor from a human pancreatic tumor that caused acromegaly. Science 1982; 218: 585–7
   PubMed Web of Science ®Google Scholar
• Rivier J, Spiess J, Thorner M, Vale W. Characterization of a growth hormone‐releasing factor from a human pancreatic islet tumor. Nature 1982; 300: 276–8
   PubMed Web of Science ®Google Scholar
• Ling N, Esch F, Böhlen P, Brazeau P, Wehrenberg W P, Guillemin R. Isolation, primary structure, and synthesis of human hypothalmic somatocrinin; growth hormone‐releasing factor. Proc Natl Acad Sci USA 1984; 81: 4302–6
   PubMed Web of Science ®Google Scholar
• Brazeau P, Ling N, Böhlen P, Esch F, Ylng S ‐Y., Guillemin R. Growth hormone‐releasing factor, somatocrinin, releases pituitary growth hormone in vitro. Proc Natl Acad Sci USA 1982; 79: 7909–13
   PubMed Web of Science ®Google Scholar
• Spless J, Rivler J, Vale W. Characterization of rat hypothalamic growth hormone‐releasing factor. Nature 1933; 303: 532–5
   Google Scholar
• Frohman L A, Jansson J ‐O. Growth hormone‐releasing hormone. Endocrin Rev 1986; 7: 223–52
   PubMed Web of Science ®Google Scholar
• Thorner M O, Rivier J, Spiess J, et al. Human pancreatic growth hormone‐releasing faclor selectively stimulates growth hormone secretion in man. Lancet 1983; 1: 24–8
   PubMed Web of Science ®Google Scholar
• Rosenthal S M, Schriock E A, Kaplan S L, Guillemin R, Grumbach M M. Synthetic human pancreas growth hormone‐releasing factor (hpGRH 1–44‐NH2) stimulates growth hormone secretion in normal men. J Clin Endocrinol Metab 1983; 57: 677–9
   PubMed Web of Science ®Google Scholar
• Chlhara K, Kodama H, Kaji H, et al. Augmentation by propranol of growth hormone‐releasing hormone‐(1–44)‐NH 2‐induced growth hormone release in normal short and normal children. J Clin Endocrinol Metab 1985; 61: 229–33
   PubMed Web of Science ®Google Scholar
• Bloch B, Galllard R C, Brazeau P, Lin H D, Ling N. Topographical and ontogenetic study of the neurons producing growth hormone‐releasing factor in human hypothalamus. Regul Pept 1984; 8: 21–31
   PubMedGoogle Scholar
• Frohman L A, Thominet J L, Webb C B, et al. Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone‐releasing factor in man. J Clin Invest 1984; 73: 1304–11
   PubMed Web of Science ®Google Scholar
• Thorner M O, Frohman L A, Leong O A, et al. Extrahypothalamic growth hormone‐releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J Clin Endocrinol Metab 1984; 59: 846–9
   PubMed Web of Science ®Google Scholar
• Donnadieu M, Evain‐Brion D, Tonon M C, Vaudry H, Job J ‐C. Variations of plasma growth hormone (GH)‐relaasing factor levels during GH stimulation tests in children. J Clin Endocrinol Metab 1984; 69: 1132–4
   Google Scholar
• Penny E S, Patience R L, Sopwith A M, Wass J AH, Besser G M, Rees L H. Characterization by high performance liquid chromatography of circulating growth hormone‐releasing factors in a human plasma. J Endocrinol 1985; 105: R1–R4
   PubMed Web of Science ®Google Scholar
• Leppäluoto J, Tapanalnen P, Knip M. Heat exposure elevates plasma immunoreactive growth hormone‐releasing hormone levels in man. J Clin Endocrinol Metab 1987; 65: 1035–8
   PubMed Web of Science ®Google Scholar
• Tapanalnen P, Knip M, Lautala P, Leppäluoto J. Variable plasma growth hormone (GH)‐releasing hormone and GH response to clonidine, L‐dopa, and insulin in normal men. J Clin Endocrinol Metab 1988; 67: 845–9
   PubMed Web of Science ®Google Scholar
• Lina L, Carolto M C, Dall'Ara A, Cocchi D. Significance of circulating immunocreative growth hormone‐releasing hormone: CNS vs. peripheral source. 70th Annual Meeting of the Endocrine Society. June, 1988. New Orleans, LA, 8–11, abstract 261
   Google Scholar
• Saito H, Saito S, Yamazaki R, Hosol E. Clinical value of radioimmunoassay of plasma growth hormone‐releasing factor. Lancet 1984; 2: 401–2
   PubMed Web of Science ®Google Scholar
• Smith P J, Pringle P J, Rafferty B, Brook C GD. The relationship between endogenous immunocreative GRH and GH secretion. J Endocrinol 1985; 104: 86, Suppl:
   Google Scholar
• Tapanainen P, Rantala H, Leppäluoto J, Lautala P, Käär M L, Knip M. Nocturnal release of immunoreactive growth hormone (GH)‐releasing hormone and GH in normal children. Pediatr Res 1989; 26: 404–9
   PubMed Web of Science ®Google Scholar
• Brazeau P, Vale W, Burgus R, et al. Hypothalmic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973; 179: 77–9
   PubMed Web of Science ®Google Scholar
• Hall R, Besser G M, Schally A V, et al. Action of growth hormone‐release inhibitory hormone in healthy men and in acromegaly. Lancet 1973; 2: 581–4
   PubMed Web of Science ®Google Scholar
• Prange‐Hansen A P, Orskov H, Seyer‐Hansen K, Lund‐baek K. Some actions of growth hormone‐release inhibiting factor. Br Med J 1973; 3: 523–4
   PubMed Web of Science ®Google Scholar
• Mortimer C H, Tunbrldge W MB, Carr D, et al. Effects of growth hormone‐release‐inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet 1974; 1: 697–701
   PubMed Web of Science ®Google Scholar
• Wehrenberg W B, Brazeau P, Luben R, Böhlen P, Guillemin R. Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). Endocrinology 1982; 111: 2147–8
   PubMed Web of Science ®Google Scholar
• Llapl C, Evain‐Brlon O, Argente J, Vaudry H, Donnadieu M. Negative correlation between peripheral plasma somatostatin levels and GH responses to GHRH stimulation tests in children. Acta Endocrinol 1986; 113: 1–4
   PubMedGoogle Scholar
• Rosskamp R, Becker M, Haverkamp F, et al. Plasma levels of growth hormone‐releasing hormone and somatostatin in response to a mixed meal and during sleep in children. Acta Endocrinol 1987; 116: 549–54
   PubMedGoogle Scholar
• Frohman L A, Downs T R, Katakami H, Jansson J ‐O. The interaction of growth hormone‐releasing hormone and somatostatin in the regulation of growth hormone secretion. Growth hormone: basic and clinical aspects, O Isaksson, C Binder, K Hall, B Hökfelt. Excerpta Medica International Congress Series, Amsterdam 1987; 748: 63–77
   Google Scholar
• Ferland L, Labrie F, Jobin M, Arimura A, Schally A V. Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion. Biochem Biophys Res Commun 1976; 68: 149–56
   PubMed Web of Science ®Google Scholar
• Wehrenberg W B, Brazeau P, Ling N, Textor G, Guillemin R. Pituitary growth hormone response in rats during a 24‐hour infusion of growth hormone‐releasing factor. Endocrinology 1984; 114: 1613–6
   PubMed Web of Science ®Google Scholar
• Katakami H, Downs T R, Frohman L A. Inhibitory effect of hypothalamic medial preoptic area somatostatin (SRTIF) on GH‐releasing hormone (GRH) in the rat. 68th Annual Meeting of the Endocrine Society. June, 1986. Anaheim, CA, 26–27, abstract 65
   Google Scholar
• Vance M L, Borges J LC, Kaiser D L, et al. Human pancreatic tumor growth hormone‐releasing factor: dose‐response relationships in normal man. J Clin Endocrinol Metab 1984; 58: 838–44
   PubMed Web of Science ®Google Scholar
• Vance M L, Kaiser D L, Evans W S, et al. Evidence for a limited growth hormone (GH)‐releasing hormone (GHRH)‐releasable quantity of GH: effects of 6‐hour infusions of GHRH on GH secretion in normal man. J Clin Endocrinol Metab 1985; 60: 370–5
   PubMed Web of Science ®Google Scholar
• Webb C B, Vance M L, Thorner M O, et al. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor: intermittent secretion or response attenuation. J Clin Invest 1984; 74: 96–103
   PubMed Web of Science ®Google Scholar
• Camanni F, Ghigo E, Mazza E, . Aspects of neurotransmitter control of GH secretion: basic and clinical studies. Advances in growth hormone and growth factor research, E Müller, D Cocchi, V Locatelli, et al. Pythagora Press, Roma‐Milano 1989; 263–81
   Google Scholar
• Müller E E. Neural control of somatotropic function. Physiol Rev 1987; 67: 962–1053
   PubMed Web of Science ®Google Scholar
• Froesch E R, Schmid C, Schwander J, Zapf J. Actions of insulin‐like growth factors. Ann Rev Physiol 1985; 47: 443–67
   PubMed Web of Science ®Google Scholar
• Casella S J, Han V K, D'Ercole A J, Svoboda M E, Van Wyk J J. Insulin‐like growth factor II binding to the type I somatomedin receptor: evidence for two high affinity binding sites. J Biol Chem 1986; 261: 9268–73
   PubMed Web of Science ®Google Scholar
• Rosenfeld R G, Lamson G, Pham H, et al. Insulin‐like growth factor binding proteins. Rec Progr Horm Res 1990; 46: 99–163
   PubMedGoogle Scholar
• Rutanen E M, Pekonen F. Insulin‐like growth factors and their binding proteins. Acta Endocrinol 1990; 123: 7–13
   PubMedGoogle Scholar
• Lamson G, Gludlce L C, Rosenfeld R G. Insulin‐like growth factor binding proteins: structural and molecular relationships. Growth Factors 1991; 5: 19–28
   PubMedGoogle Scholar
• Clemmons D R, van Wyk J J. Factors controlling blood concentrations of somatomedin C. Clin Endocrinol Metab 1984; 13: 113–43
   PubMedGoogle Scholar
• Isaksson O GP, Llndahl A, Nilsson A, Isgaard J. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocrine Rev 1987; 8: 426–38
   PubMed Web of Science ®Google Scholar
• Hirt H, Kimelman J, Birnbaum M J, et al. The human growth hormone gene locus: structure, evolution and allelic variations. DNA 1987; 6: 59–70
   PubMedGoogle Scholar
• Baumann G, Stolar M W, Amburn K, et al. A specific growth hormone binding protein in human plasma: initial characterization. J Clin Endocrinol Metab 1986; 62: 134–41
   PubMed Web of Science ®Google Scholar
• Phillips J A. Regulation of and defects in expression of growth hormone genes, O Isaksson, C Binder, K Hall, B Hökfelt. Excerpta Medica International Congress Series, III, Amsterdam 1987; 748: 11–27
   Google Scholar
• Honda Y, Takahashi K, Takahashi S, et al. Growth hormone secretion during nocturnal sleep in normal subjects. J Clin Endocrinol Metab 1969; 29: 20–9
   PubMed Web of Science ®Google Scholar
• Thorner M O, Rogol A D. Neuroendocrine regulation of growth hormone secretion. Human growth hormone, progress and challenges, L E Underwood. Marcel Dekker Inc., New York 1988; 113–30
   Google Scholar
• Thompson R G, Rodriguez A, Kowarski A, Migeon C J, Blizzard R M. Integrated concentrations of growth hormone correlated with plasma testosterone and bone age in preadolescent and adolescent males. J Clin Endocrinol Metab 1972; 35: 334–7
   PubMed Web of Science ®Google Scholar
• Zadik Z, Chafew S A, McCarter J, Jr, Melstas M, Kowarski A A. The influence of age on the 24‐hour integrated concentration of growth hormone. J Clin Endocrinol Metab 1985; 60: 513–16
   PubMed Web of Science ®Google Scholar
• Albertsson‐Wikland K, Rosberg S. Analyses of 24‐hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab 1988; 67: 493–500
   PubMed Web of Science ®Google Scholar
• Minuto F, Barreca A, Ferrini S, Mazzocchi G, Del Monte P, Giordano G. Growth hormone secretion in pubertal and adult subjects. Acta Endocrinol 1982; 99: 161–5
   PubMedGoogle Scholar
• Argente J, Evain‐Brion D, Munoz‐Villa A, Gamier P, Hernandez M, Donnadieu M. Relationship of plasma growth hormone‐releasing hormone levels to pubertal changes. J Clin Endocrinol Metab 1986; 63: 680–2
   PubMed Web of Science ®Google Scholar
• Kostyo J L. The growth‐promoting activity of growth hormone. Human growth hormone, progress and challenges, L E Underwood. Marcel Dekker Inc., New York 1988; 63–73
   Google Scholar
• Schoenle E, Zapf J, Froesch E R. Insulin‐like growth factors I and II stimulate growth of hypophysectomized rats. Diabetologia 1982; 23: 199
   Web of Science ®Google Scholar
• Schoenle E, Zapf J, Humbel R E, Froesch E R. Insulin‐like growth factor I stimulates growth in hypophysectomized rats. Nature 1982; 296: 252–3
   PubMed Web of Science ®Google Scholar
• Rose S R, Ross J L, Uriarte M, et al. The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. N Engl J Med 1988; 319: 201–7
   PubMed Web of Science ®Google Scholar
• Roth J, Glick S M, Yalow R S, Berson S A. Hypoglycemia: a potent stimulus to secretion of growth hormone. Science 1963; 140: 987–8
   PubMed Web of Science ®Google Scholar
• The Health Services Human Growth Hormone Committee. Comparison of the intravenous insulin and oral clonidine tolerance tests for growth hormone secretion. Arch Dis Child 1981; 56: 852–4
   PubMed Web of Science ®Google Scholar
• Boyd A E, Lebovitz H E, Pfeiffer J B. Stimulation of human growth hormone secretion by L‐dopa. N Engl J Med 1970; 283: 1425–9
   PubMed Web of Science ®Google Scholar
• Vanderschueren‐Lodeweyckx M, Wolter R, Malvaux P, et al. The glucagon stimulation test: effect on plasma growth hormone and on immunocreative insulin, Cortisol and glucose in children. J Pediatr 1974; 85: 182–7
   PubMed Web of Science ®Google Scholar
• Merimee T J, Lillicrap D A, Rabinovitz D. Effect of arginine on serum levels of human growth hormone. Lancet 1965; 2: 668–70
   PubMed Web of Science ®Google Scholar
• Hamilton W, Hussein D M. Growth hormone response to prostaglandin E 2. Acta Pediatr Scand 1979; 68: 251–6
   PubMed Web of Science ®Google Scholar
• Frasier S D. A review of growth hormone stimulation tests in children. Pediatrics 1974; 53: 929–37
   PubMed Web of Science ®Google Scholar
• Brook C GD, Hindmarsh P C, Smith P J, Stanhope R. Clinical features and investigation of growth hormone deficiency. Clin Endocrinol Metab 1986; 15: 479–93
   PubMedGoogle Scholar
• Takahashi Y, Kipnis D M, Daughaday W H. Growth hormone secretion during sleep. J Clin Invest 1968; 47: 2079–90
   PubMed Web of Science ®Google Scholar
• Lacey K A, Hewison A, Parkin J M. Exercise as a screening test for growth hormone deficiency in children. Arch Dis Child 1973; 48: 508–12
   PubMed Web of Science ®Google Scholar
• Hindmarsh P C, Smith P J, Taylor B J, et al. Comparison between a physiological and a pharmacological stimulus of growth hormone secretion: response to stage IV sleep and insulin‐induced hypoglycaemia. Lancet 1985; 2: 1033–5
   PubMed Web of Science ®Google Scholar
• Geisen K, Meder R. The effect of heat on the level of human growth hormone in the serum. Z Kinderheilkd 1969; 106: 308–13
   PubMedGoogle Scholar
• Dacou‐Voutetakis C, Drakopoulou M, Maniati M. Growth hormone levels during sleep in children. Pediatr Adolesc Endocrinol 1983; 12: 44–52
   Google Scholar
• Bercu B B, Shulman D, Root A W, Spiliots B E. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion. J Clin Endocrinol Metab 1986; 63: 709–16
   PubMed Web of Science ®Google Scholar
• Albertsson‐Wikland K, Westphal O, Westgren U. Daily subcutaneous administration of human growth hormone in growth hormone deficient children. Acta Paediatr Scand 1986; 75: 89–97
   PubMed Web of Science ®Google Scholar
• Schulman D I, Bercu B B. Evaluation of growth hormone secretion: provocative testing vs. endogenous 24‐hour growth hormone profile. Acta Paediatr Scand 1987, Suppl. 337: 61–71
   Google Scholar
• Sukegawa I, Hizuka N, Takano K, et al. Urinary growth hormone (GH) measurements are useful for evaluating endogenous GH secretion. J Clin Endocrinol Metab 1988; 66: 1119–23
   PubMed Web of Science ®Google Scholar
• Tanaka T, Yoshizawa A, Miki Y, Ito J. Clinical usefulness of urinary growth hormone measurement in short children. Acta Paediatr Scand 1990; 366: 155–8, (Suppl)
   Google Scholar
• Schriock E A, Hulse J A, Harris D A, Kaplan S L, Grumbach M M. Evaluation of hypothalamic dysfunction in growth hormone (GH)‐deficient patients using single versus multiple doses of GH‐releasing hormone (GHRH‐44) and evidence for diurnal variation in somatotroph responsiveness to GHRH in GH‐deficient patients. J Clin Endocrinol Metab 1987; 65: 1177–82
   PubMed Web of Science ®Google Scholar
• Kajiwara S, Igarashi N, Imura E, Sato T. Correlation between pituitary growth hormone reserve and degree of growth failure in children with short stature. Eur J Pediatr 1988; 147: 584–87
   PubMed Web of Science ®Google Scholar
• Ranke M B, Gruhier M, Rosskamp R, et al. Testing with growth hormone‐releasing factor (GRH 1–29) NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency. Eur J Pediatr 1986; 145: 485–92
   PubMed Web of Science ®Google Scholar
• Chatelain P. European collaborative study on the effect of synthetic 1–44 growth‐hormone‐releasing factor (GRF) on plasma growth hormone (GH) in prepubertal children with growth failure. Pediatr Res 1985; 19: 610
   Web of Science ®Google Scholar
• Borges J LC, Blizzard R M, Gelato M C, et al. Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet 1983; 1: 119–24
   Google Scholar
• Schriock E A, Lustig R H, Rosenthal S M, Kaplan S L, Grumbach M M. Effect of growth hormone (GH)‐releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency. J Clin Endocrinol Metab 1984; 58: 1043–49
   PubMed Web of Science ®Google Scholar
• Schriock E A, Rosenthal S M, Egli C A, . Studies with growth hormone‐releasing factor (GRF) in the human: effect of a single pulse, or multiple pulses of GRF on growth hormone (GH) release in normal and GH‐deficient children and adults. Human growth hormone, S Raiti, R A Tolman, et al. Plenum Publishing Corp., New York 1986; 387–403
   Google Scholar
• Furlanetto R W, Underwood L, Van Wyk J J, D'Ercole A J. Estimation of somatomedin‐C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 1977; 60: 648–657
   PubMed Web of Science ®Google Scholar
• Zapf J, Walter H, Froesch E R. Radioimmunological determination of insulin‐like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest 1981; 68: 1321–1330
   PubMed Web of Science ®Google Scholar
• Furlanetto R W. Insulin‐like growth factor measurements in the evaluation of growth hormone secretion. Horm Res 1990; 33(Suppl 4)25–30
   PubMedGoogle Scholar
• Furlanetto R W, Marino J M. Radioimmunoassays of somatomedin C/insulin‐like growth factor I. Methods Enzymol 1985; 146: 216
   Web of Science ®Google Scholar
• Merimee T J, Zapf J, Froesch E R. Insulin‐like growth factors in the fed and fasted states. J Clin Endocrinol Metab 1982; 55: 999–1002
   PubMed Web of Science ®Google Scholar
• Rosenfeld R G, Wilson G M, Lee P OK, Hintz R L. Insulinlike‐growth factors I and II in evaluation of growth retardation. J Pediatr 1986; 109: 428–33
   PubMed Web of Science ®Google Scholar
• Blum W F, Ranke M B, Kletzmann K, Ganggel E, Zeisel H J, Bierich J R. A specific radioimmunoassay for the growth hormone (GH)‐dependent somatomedin‐binding protein: it's use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990; 70: 1292–8
   PubMed Web of Science ®Google Scholar
• Blum W F, Ranke M B. Use of insulin‐like growth factor‐binding protein 3 for evaluation of growth disorders. Horm Res 1990; 33(Suppl 4)31–7
   PubMedGoogle Scholar
• Brook C GD, Hindmarsh P C, Smith P J. Is growth hormone deficiency a useful diagnosis?. Acta Paediatr Scand 1987, Suppl 33: 70–5
   PubMed Web of Science ®Google Scholar
• Vanderschuerer‐Lodeweyck Z. The establishment of growth hormone deficiency in children. International Growth Monitor 1990; 1: 3–9
   Google Scholar
• Zadik Z, Chalew S A, Raiti S, Kowarski A A. Do short children secrete insufficient growth hormone?. Pediatrics 1985; 76: 355–60
   PubMed Web of Science ®Google Scholar
• Illig R, Prader A, Fernandez A, Zachmann M. Hereditary prenatal growth hormone deficiency with increased growth hormone antibody formation. Symposium der Deutschen Gesellschaft für Endokrinologie 1970; 16: 246–7
   Google Scholar
• Hindmarsh P C, Brook C GD. Auxological and biochemical assessment of short stature. Acta Paediatr Scand 1988, Suppl 343: 73–6
   Google Scholar
• Raben M S. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 1958; 18: 901–3
   PubMed Web of Science ®Google Scholar
• Powell‐Jackson, Weller J, Kennedy P, Preece M A, Whitcombe E M, Newson‐Davis J. Creutzfeldt‐Jakob disease after administration of human growth hormone. Lancet 1985; 2: 244–6
   PubMed Web of Science ®Google Scholar
• Gibbs C J, Jr, Joy A, Heffner R, Franko M, et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt‐Jakob disease in a recipient of pituitary‐derived human growth hormone. N Engl J Med 1985; 313: 734–8
   PubMed Web of Science ®Google Scholar
• Fryklund L. Production of authentic recombinant somatropin. Acta Paediatr Scand 1987, Suppl 331: 5–8
   Google Scholar
• Kaplan S L, Underwood L E, August G P, et al. Clinical studies with recombinant‐DNA‐derived methionyl human growth hormone in growth hormone‐deficient children. Lancet 1986; 1: 697–700
   PubMed Web of Science ®Google Scholar
• Hindmarsh P C, Brook C GD. Effect of growth hormone on short normal children. Br Med J 1987; 295: 573–7
   PubMed Web of Science ®Google Scholar
• Albertsson‐Wlkland K, Aronson S, Nilsson K O, et al. Recombinant somatotropin in treatment of growth hormone deficient children in Sweden and Finland. Acta Paediatr Scand 1980, Suppl 347: 176–80
   Google Scholar
• Prader A, Zachmann M, Poley J R, Illig R, Szeky J. Longterm treatment with human growth hormone (Raben) in small doses. Evaluation of 18 hypopituitary patients. Helv Paediatr Acta 1967; 22: 423–40
   PubMedGoogle Scholar
• Milner R DG, Russell‐Fraser T, Brook C GD, et al. Experience with human growth hormone in Great Britain: the report of the MRC working party. Clin Endocrinol 1979; 11: 15–38
   PubMed Web of Science ®Google Scholar
• Ranke M B, Blerich J R. Treatment of growth hormone deficiency. Clin Endocrinol Metab 1986; 15: 495–510
   PubMedGoogle Scholar
• Zuppinger K, Joss E, Roten A, Schwartz H P, Aebl C. Endresultate bei hypophyzären Kleinwuchs nach Wachstumshormontherapie. Med Praxis 1980; 34: 1197–204
   Google Scholar
• Lenko H L, Leisti S, Perheentupa J. The efficiency of growth hormone in different types of growth failure. An analysis of 101 cases. Eur J Pediatr 1982; 138: 241–9
   PubMed Web of Science ®Google Scholar
• Ad Hoc Committee on Growth Hormone Usage, The Lawson Wilkins Pediatric Endocrine Society, and Committee on Drugs. Growth hormone in the treatment of short stature. Pediatrics 1983; 72: 891–4
   PubMed Web of Science ®Google Scholar
• Bierich J R. Multicentre clinical trial of authentic recombinant somatropin in growth hormone deficiency. Acta Paediatr Scand 1987, Suppl 337: 135–40
   Google Scholar
• Van Vliet G, Styne D M, Kaplan S L, Grumbach M M. Growth hormone treatment for short stature. N Engl J Med 1983; 309: 1016–22
   PubMed Web of Science ®Google Scholar
• Genentech Collaborative Study Group. Idiopathic short stature; results of nine 1‐year controlled study of human growth hormone treatment. J Pediatr 1989; 115: 713–9
   PubMed Web of Science ®Google Scholar
• Albertsson‐Wlkland K, Hall K. Growth hormone treatment in short children: relationship between growth and serum insulin‐like growth factor I and II levels. J Clin Endocrinol Metab 1987; 65: 671–8
   PubMed Web of Science ®Google Scholar
• Butenandt O. Die konstitutionelle entwicklungsverzögerung—untersuchungen zur therapie mit wachstumshormon. Klin Pediatr 1984; 196: 69–72
   PubMed Web of Science ®Google Scholar
• Tanner J M, Whltehouse R H, Hughes P CR, Vlnce F P. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with hormone deficiency, low birth‐weight, inherited smallness, Turner's syndrome, and other complaints. Arch Dis Child 1971; 46: 745–82
   PubMed Web of Science ®Google Scholar
• Rüdman D, Goldsmith M, Kutner M, Blackston D. Effect of growth hormone and oxandrolone singly and together on growth rate in girls with X chromosome abnormalities. J Pediatr 1980; 96: 132–5
   PubMed Web of Science ®Google Scholar
• Raiti S, Moore W V, Van Vliet G, Kaplan S L, The National Hormone and Pituitary Program. Growth‐stimulating effects of human growth hormone therapy in patients with Turner's syndrome. J Pediatr 1986; 109: 944–9
   PubMed Web of Science ®Google Scholar
• Rosenfeld R G, Hintz R L, Johanson A J, et al. Three year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome. J Pediatr 1988; 113: 393–400
   PubMed Web of Science ®Google Scholar
• Ross R JM, Grossman A, Smith B, et al. Evidence that growth hormone inhibits the GH response to growth hormone‐releasing factor in man. J. Endocrinol 1985; 107(Suppl 28)
   Google Scholar
• Thorner M O, Reschke J, Chitwood J, et al. Acceleration of growth in two children treated with human growth hormone‐releasing factor. N Engl J Med 1985; 312: 4–9
   PubMed Web of Science ®Google Scholar
• Rochlccloll P E, Tauber M T, Coude F X, et al. Results of 1‐year growth hormone (GH)‐releasing hormone (1–44) treatment on growth, somatomedin‐C, and 24‐hour GH secretion in six children with partial GH‐deficiency. J Clin Endocrinol Metab 1987; 65: 268–74
   PubMed Web of Science ®Google Scholar
• Ross R J, Rodda C, Tsagarakls S, et al. Treatment of growth hormone deficiency with growth hormone‐releasing hormone. Lancet 1987; 1: 5–8
   PubMed Web of Science ®Google Scholar
• Smith P J, Brook C G, Rivier J, Vale W, Thorner M O. Nocturnal pulsatile growth hormone releasing hormone treatment in growth hormone deficiency. Clin Endocrinol 1986; 25: 35–44
   PubMed Web of Science ®Google Scholar
• Low L CK, Wang C, Cheung P T, et al. Long term pulsatile growth hormone (GH)‐releasing hormone therapy in children with GH deficiency. J Clin Endocrinol Metab 1988; 66: 611–7
   PubMed Web of Science ®Google Scholar
• Plntor C, Cella S G, Loche S, et al. Clonidine treatment for short stature. Lancet 1987; 1: 1226–30
   PubMed Web of Science ®Google Scholar
• Loche S, Puggloni R, Fannl T, Ceila S G, Müller E E, Plntor C. Augmentation of growth hormone secretion in children with constitutional growth delay by short term clonidine administration: a pulse amplitude‐modulated phenomenon. J Clin Endocrinol Metab 1989; 68: 426–30
   PubMed Web of Science ®Google Scholar
• Pescovitz H, Tan E. Lack of benefit of clonidine treatment for short stature using double‐blind, placebo‐controlled trial. Lancet 1988; 2: 874–7
   PubMed Web of Science ®Google Scholar
• Laron Z, Klinger B, Erster B, Anln S. Effect of acute administration of insulin‐like growth factor I in patients with Laron‐type dwarfism. Lancet 1988; 2: 1170–2
   PubMed Web of Science ®Google Scholar
• Walker J L, Gfnalska‐Malinovska M, Romer T E, Pucilowska J B, Underwood L E. Effects of the infusion of insulin‐like growth factor 1 in a child with growth hormone insensitivity syndrome (Laron dwarfism). N Engl J Med 1991; 324: 1483–8
   PubMed Web of Science ®Google Scholar
• Hermanussen M, Geiger‐Benoit K, Burmeister J, Slppell W G. Can the knemometer shorten the time for growth rate assessment?. Acta Paediatr Scand 1987, Suppl 337: 30–6
   PubMed Web of Science ®Google Scholar
• Albertsson‐Wikland K, Isaksson O, Rosberg S, Westgren U, Westphal O. Frequency and mode of growth hormone administration: relationship to growth in prepubertal children. Acta Endocrinol 1983, Suppl 256: 215
   Google Scholar
• Hermanussen M, Sippell W G, Valk I M. Knemometric monitoring of early effects of human growth hormone on leg length in children with growth hormone deficiency. Lancet 1985; 1069–71
   PubMed Web of Science ®Google Scholar
• D'Ercole A J, Underwood L E, Van Wyk J J. Serum somatomedin‐C in hypopituitarism and in other disorders of growth. J Pediatr 1977; 90: 375–81
   PubMed Web of Science ®Google Scholar
• Rosenfeld R G, Kemp S F, Hintz R L. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate. J Clin Endocrinol Metab 1981; 53: 611–17
   PubMed Web of Science ®Google Scholar
• Blethen S L, Daughaday W H, Weldon W. Kinetics of the somatomedin C/insulin‐like growth factor I: Response to exogenous growth hormone (GH) in GH‐deficient children. J Clin Endocrinol Metab 1982; 54: 986–90
   PubMed Web of Science ®Google Scholar
• Lodeweyckx M, Wolter R. Effect of growth hormone‐releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children. Horm Res 1985; 22: 32–45
   PubMedGoogle Scholar
• Hlntz R, Frane J, Sherman B, The Genentech Collaborative Group. Pretreatment IGF‐I correlates with growth response to GH in hypopituitarism: the importance of acid separation. Pediatr Res 1988; 24: 522
   Web of Science ®Google Scholar
• Ristell J, Nlemi S, Trlvedl P, Mäentausta O, Mowat A P, Risteli L. Rapid equilibrium radioimmunoassay for the amino‐terminal propeptide of human type III procollagen. Clin Chem 1988; 34: 715–8
   PubMed Web of Science ®Google Scholar
• Tapanainen P, Risteli L, Knip M, Käär M ‐L., Risteli J. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy. J Clin Endocrinol Metab 1988; 67: 1244–9
   PubMed Web of Science ®Google Scholar
• Trivedi P, Hindmarsh P, Risteli J, Risteli L, Mowat A, Brook C. Growth velocity, growth hormone therapy and serum concentrations of the aminoterminal propeptide of type III procollagen. J Pediatr 1989; 114: 225–30
   PubMed Web of Science ®Google Scholar
• Danne T, Grüters A, Schuppan D, Quantas N, Enders I, Weber B. Relationship of procollagen type III propeptide—related antigen in serum to somatic growth in healthy children and patients with growth disorders. J Pediatr 1989; 114: 257–60
   PubMed Web of Science ®Google Scholar
• Carey D E, Goldberg B, Ratzan S K, Rubin K R, Rowe D W. Radioimmunoassay for type I procollagen in growth hormone‐deficient children before and during treatment with growth hormone. Ped Res 1985; 19: 8–11
   PubMed Web of Science ®Google Scholar
• Hyams J S, Carey D E, Lelchtner A M, Goldberg B D. Type I procollagen as a biochemical marker of growth in children with inflammatory bowel disease. J Pediatr 1986; 109: 619–24
   PubMed Web of Science ®Google Scholar
• Tapanainen P, Risteli L, Knip M, Kemppainen L, Käär M ‐L., Risteli J. Collagen metabolities in prediction of response to growth hormone (GH) therapy in short children. Horm Pes 1990; 33(Suppl 3)20
   PubMedGoogle Scholar
• Delmas P D, Malaval L, Arcot M E, Meunier P J. Serum bone Gla‐protein compared to bone histomorphometry in endocrine diseases. Bone 1985; 6: 339–41
   PubMed Web of Science ®Google Scholar
• Johansen J S, Giwercman A, Hartwell D, et al. Serum bone Gla‐protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin‐like growth factor I and serum testosterone. J Clin Endocrinol 1988; 67: 273–8
   PubMed Web of Science ®Google Scholar
• Johansen J S, Jensen S B, Rüs B J, Rasmussen L, Zachmann M, Christiansen C. Serum bone Gla‐protein: a potential marker of growth hormone (GH) deficiency and the response to GH‐therapy. J Clin Endocrinol Metab 1990; 71: 122–6
   PubMed Web of Science ®Google Scholar